CI_ChemClass CI_with has_Ingredient has_MoA has_PE may_treat drug associated with AE in adult used to treat disease Asthma [Disease/Finding] Atrial Fibrillation [Disease/Finding] Atrial Flutter [Disease/Finding] Bradycardia [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Heart Failure [Disease/Finding] Hypotension [Disease/Finding] Pulmonary Edema [Disease/Finding] Shock, Cardiogenic [Disease/Finding] Sick Sinus Syndrome [Disease/Finding] Tachycardia, Supraventricular [Disease/Finding] Ventricular Fibrillation [Disease/Finding] Bronchial Hyperreactivity [Disease/Finding] Kidney Failure [Disease/Finding] Tachycardia, Ventricular [Disease/Finding] gatifloxacin [Chemical/Ingredient] sparfloxacin [Chemical/Ingredient] Cisapride [Chemical/Ingredient] Sotalol [Chemical/Ingredient] Arterial Vasodilation [PE] Negative Chronotropy [PE] Negative Inotropy [PE] Adrenergic beta1-Antagonists [MoA] Adrenergic beta2-Antagonists [MoA] S [Preparations] SOTALOL http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019865s020lbl.pdf C0037707 Ingredient C20188 Sotalol <VANDF_Record>50.6^2782^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>2782</VA_IEN> <VANDF_Record>50.416^3470^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>3470</VA_IEN> Active N0000148334 SOTALOL A6D97U294I 9947 4020814 heart conduction disease fatigue AE bradycardia AE dyspnea AE asthenia AE dizziness AE arrhythmia AE torsades de pointes AE